论文部分内容阅读
目的:研究分析曲美他嗪联合阿托伐他汀治疗不稳定型心血管疾病的应用价值。方法:选取2014年2月~2015年2月期间收治的不稳定型心血管疾病患者97例,采用数字标注法随机分为观察组与对照组,对照组48例,采用硝酸酯类药物、β受体阻断剂等常规手段治疗,观察组49例,采用曲美他嗪联合阿托伐他汀给予治疗,对比两组患者临床治疗效果。结果:所有心血管疾病患者在治疗1个疗程后,血脂水平得到明显控制,观察组治疗效果显著优于对照组(P<0.05)差异有统计学意义。结论:应用曲美他嗪联合阿托伐他汀治疗不稳定型心血管疾病其疗效确切,其调节血脂的药用价值较高,值得临床应用。
Objective: To study the clinical value of trimetazidine combined with atorvastatin in the treatment of unstable cardiovascular diseases. Methods: A total of 97 patients with unstable cardiovascular diseases were enrolled from February 2014 to February 2015. The patients were randomly divided into observation group (n = 48) and control group (n = 48). Nitrates, β Receptor blockers and other conventional means of treatment, the observation group of 49 cases, the use of trimetazidine combined with atorvastatin treatment, the clinical efficacy of two groups were compared. Results: After treatment of 1 course of treatment, the level of blood lipids was significantly controlled in all patients with cardiovascular disease. The treatment effect of the observation group was significantly better than that of the control group (P <0.05). Conclusion: The application of trimetazidine combined with atorvastatin in the treatment of unstable cardiovascular disease is effective and its medicinal value of regulating blood lipids is high, which is worthy of clinical application.